Best CRT - P Hospitals in Israel

Rabin Medical Center is a trusted healthcare provider for CRT - P, offering advanced cardiac rhythm management supported by experienced specialists and modern medical infrastructure. Established in 1996, the JCI hospital is situated in Petah Tikva, Israel and has 1300 beds.

Cardiac Resynchronization Therapy with Pacemaker (CRT-P) can help improve the coordination of ventricular contractions in patients with heart failure and electrical conduction disorders. Unlike CRT-D, CRT-P provides resynchronization therapy without a defibrillator function. During implantation, leads are positioned in appropriate chambers of the heart and connected to a pulse generator placed beneath the skin. Comprehensive cardiac evaluation before treatment and regular device monitoring are important for effective long-term management.

Sheba Medical Center offers advanced CRT-P (Cardiac Resynchronization Therapy with Pacemaker) using modern cardiac device implantation techniques and internationally accepted treatment protocols. Established in 1948, the JCI hospital is located in Ramat Gan, Israel and has 1900 beds, providing comprehensive cardiovascular care for local and international patients.

CRT-P is a device-based treatment used for patients with heart failure and abnormal electrical conduction that causes the heart's ventricles to beat out of sync. The device delivers coordinated electrical impulses to help synchronize ventricular contractions and improve cardiac efficiency. Before implantation, doctors assess heart rhythm, ventricular function, and overall cardiac health through ECG, echocardiography, and other tests. Regular follow-up helps monitor device function and the patient's response to therapy.

Herzliya Medical Center is a trusted healthcare provider for CRT - P, offering advanced cardiac rhythm management supported by experienced specialists and modern medical infrastructure. Established in 1983, the hospital is situated in Herzliya, Israel and has 120 beds.

Cardiac Resynchronization Therapy with Pacemaker (CRT-P) can help improve the coordination of ventricular contractions in patients with heart failure and electrical conduction disorders. Unlike CRT-D, CRT-P provides resynchronization therapy without a defibrillator function. During implantation, leads are positioned in appropriate chambers of the heart and connected to a pulse generator placed beneath the skin. Comprehensive cardiac evaluation before treatment and regular device monitoring are important for effective long-term management.

Assuta Hospital is a trusted healthcare provider for CRT - P, offering advanced cardiac rhythm management supported by experienced specialists and modern medical infrastructure. Established in 1934, the JCI hospital is situated in Tel Aviv, Israel and has 300 beds.

Cardiac Resynchronization Therapy with Pacemaker (CRT-P) can help improve the coordination of ventricular contractions in patients with heart failure and electrical conduction disorders. Unlike CRT-D, CRT-P provides resynchronization therapy without a defibrillator function. During implantation, leads are positioned in appropriate chambers of the heart and connected to a pulse generator placed beneath the skin. Comprehensive cardiac evaluation before treatment and regular device monitoring are important for effective long-term management.

Tel Aviv Sourasky Medical Center -Ichilov Hospital provides specialized CRT - P with a focus on precise device implantation, patient safety, and long-term cardiac management. Established in 1963, the JCI hospital is located in Tel Aviv, Israel and operates 1500 beds with modern cardiac infrastructure.

CRT-P is designed to provide cardiac resynchronisation by coordinating the contractions of the heart's ventricles through controlled electrical stimulation. It may be used in carefully patients with heart failure and specific electrical conduction abnormalities. Unlike a CRT-D system, CRT-P does not include an implantable defibrillator. Doctors perform detailed cardiac testing before implantation to determine suitability and plan the procedure, followed by regular device checks and cardiology follow-up to monitor therapy.